Clearance Summary
REMPRESS AND ANGIOGRAPHY CONTRAST DELIVERY SYSTEM REMPRESS received FDA 510(k) clearance under submission number K092896, sponsored by Nemoto Kyorindo Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2010-10-29.
- Submission: K092896
- Applicant / Sponsor: Nemoto Kyorindo Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1650
- Decision date: 2010-10-29
Classification & Regulation
This clearance is catalogued under FDA product code DXT and 21 CFR 870.1650, within the Cardiovascular review panel as a Class II device.